Cargando…

Factors associated with cardiac allograft vasculopathy after heart transplantation

INTRODUCTION: Cardiac allograft vasculopathy (CAV) is a major threat to long-term survival after heart transplantation (HT). AIM: To determine factors associated with CAV detection in patients after HT. MATERIAL AND METHODS: We analyzed 299 consecutive patients after HT who underwent routine visits...

Descripción completa

Detalles Bibliográficos
Autores principales:	Szczurek-Wasilewicz, Wioletta, Hawranek, Michał, Skrzypek, Michał, Hrapkowicz, Tomasz, Gąsior, Mariusz, Warmusz, Oliwia, Szyguła-Jurkiewicz, Bożena
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Termedia Publishing House 2022
Materias:	Original Paper
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9885235/ https://www.ncbi.nlm.nih.gov/pubmed/36751283 http://dx.doi.org/10.5114/aic.2022.120370

Ejemplares similares

Investigation of the Role of Oxidative Stress and Factors Associated with Cardiac Allograft Vasculopathy in Patients after Heart Transplantation
por: Szczurek, Wioletta, et al.
Publicado: (2020)

Risk factors of cardiac allograft vasculopathy
por: Szyguła-Jurkiewicz, Bożena, et al.
Publicado: (2015)

Everolimus-eluting stents versus sirolimus-eluting stents in patients with cardiac allograft vasculopathy
por: Hawranek, Michał, et al.
Publicado: (2021)

The Utility of Pentraxin and Modified Prognostic Scales in Predicting Outcomes of Patients with End-Stage Heart Failure
por: Szczurek-Wasilewicz, Wioletta, et al.
Publicado: (2022)

Everolimus-Eluting Second-Generation Stents for Treatment of De Novo Lesions in Patients with Cardiac Allograft Vasculopathy
por: Pyka, Łukasz, et al.
Publicado: (2020)

Apelin Improves Prognostic Value of HFSS (Heart Failure Survival Score) and MAGGIC (Meta-Analysis Global Group in Chronic Heart Failure) Scales in Ambulatory Patients with End-Stage Heart Failure †
por: Szczurek, Wioletta, et al.
Publicado: (2020)

Factors Associated with Ineffectiveness of Sildenafil Treatment in Patients with End-Stage Heart Failure and Elevated Pulmonary Vascular Resistance
por: Szczurek, Wioletta, et al.
Publicado: (2020)

The role of optical coherence tomography and other intravascular imaging modalities in cardiac allograft vasculopathy
por: Dyrbuś, Maciej, et al.
Publicado: (2020)

Oxidative Stress Markers and Modified Model for End-Stage Liver Disease Are Associated with Outcomes in Patients with Advanced Heart Failure Receiving Bridged Therapy with Continuous-Flow Left Ventricular Assist Devices
por: Szyguła-Jurkiewicz, Bożena, et al.
Publicado: (2021)

Prognostic scales in advanced heart failure
por: Szczurek, Wioletta, et al.
Publicado: (2018)

The role of statins in patients after heart transplantation
por: Szyguła-Jurkiewicz, Bożena, et al.
Publicado: (2015)

Oxidative stress and inflammatory markers – the future of heart failure diagnostics?
por: Szczurek, Wioletta, et al.
Publicado: (2015)

Clinical features, management and mortality in diabetic and non-diabetic patients with heart failure – observations from the COMMIT-HF registry
por: Siedlecki, Łukasz, et al.
Publicado: (2017)

Oxidative Stress Markers in Hypertrophic Cardiomyopathy
por: Szyguła-Jurkiewicz, Bożena, et al.
Publicado: (2021)

The role of statins in chronic heart failure
por: Szyguła-Jurkiewicz, Bożena, et al.
Publicado: (2014)

Obesity in patients with end-stage heart failure
por: Król, Bogumiła, et al.
Publicado: (2018)

Mechanical circulatory support in heart failure
por: Szyguła-Jurkiewicz, Bożena, et al.
Publicado: (2016)

Comparison of coronary artery bypass grafting and percutaneous coronary intervention in patients with heart failure with reduced ejection fraction and multivessel coronary artery disease
por: Hawranek, Michał, et al.
Publicado: (2018)

The Model for End-Stage Liver Disease (MELD) can predict outcomes in ambulatory patients with advanced heart failure who have been referred for cardiac transplantation evaluation
por: Szyguła-Jurkiewicz, Bożena, et al.
Publicado: (2014)

Cardiac allograft vasculopathy in Dutch heart transplant recipients
por: Galli, G., et al.
Publicado: (2016)

Female gender and the clinical and periprocedural profile and clinical outcomes of transcatheter aortic valve implantation: experiences of a tertiary Polish centre
por: Wilczek, Krzysztof, et al.
Publicado: (2020)

Early Inflammatory Markers Are Independent Predictors of Cardiac Allograft Vasculopathy in Heart-Transplant Recipients
por: Labarrere, Carlos A., et al.
Publicado: (2014)

Accelerated Cardiac Allograft Vasculopathy in an Orthotopic Heart Transplant Recipient with Prior COVID-19
por: Parikh, Neil U., et al.
Publicado: (2023)

Revascularization in ischemic heart failure with reduced left ventricular ejection fraction. The impact of complete revascularization
por: Pyka, Łukasz, et al.
Publicado: (2017)

Cardiac allograft vasculopathy and donor age affecting permanent pacemaker implantation after heart transplantation
por: Roest, Stefan, et al.
Publicado: (2022)

The relationship between late gadolinium enhancement imaging and myocardial biopsy in the evaluation of chronic heart failure patients with suspected myocarditis
por: Nowak, Jolanta, et al.
Publicado: (2014)

Diagnosis of cardiac allograft vasculopathy in heart transplant patients using a pixelated stress perfusion analysis
por: Hanna, Alexander Benjamin
Publicado: (2019)

Diagnostic Accuracy of Dobutamine Stress Echocardiography for Detection of Cardiac Allograft Vasculopathy in Orthotopic Heart Transplant Patients
por: Mahmoodurrahman, Mohammed, et al.
Publicado: (2021)

Low-Density Lipoprotein Cholesterol Level Trends and the Development of Cardiac Allograft Vasculopathy After Heart Transplantation
por: Aleksova, Natasha, et al.
Publicado: (2021)

Heart Transplantation and Risk of Cardiac Vasculopathy Development: What Factors Are Important?
por: Sobieszczańska-Małek, Małgorzata, et al.
Publicado: (2017)

Nuclear Osteopontin Is a Marker of Advanced Heart Failure and Cardiac Allograft Vasculopathy: Evidence From Transplant and Retransplant Hearts
por: Irion, Camila Iansen, et al.
Publicado: (2020)

Early Cardiac Allograft Vasculopathy: Are the Viruses to Blame?
por: Aggarwal, Ashim, et al.
Publicado: (2012)

Cardiac allograft vasculopathy: diagnosis, therapy, and prognosis
por: Skorić, Boško, et al.
Publicado: (2014)

Coronary CTA for Surveillance of Cardiac Allograft Vasculopathy
por: Shah, Nishant R., et al.
Publicado: (2018)

The role of everolimus in treatment of cardiac allograft vasculopathy
por: Watanabe, Tetsu
Publicado: (2013)

The novel proteomic signature for cardiac allograft vasculopathy
por: Wei, Dongmei, et al.
Publicado: (2022)

Coincidence of cellular and antibody mediated rejection in heart transplant recipients – preliminary report
por: Zakliczyński, Michał, et al.
Publicado: (2014)

The Impact of Short-Term Outdoor Air Pollution on Clinical Status and Prognosis of Hospitalized Patients with Coronary Artery Disease Treated with Percutaneous Coronary Intervention
por: Desperak, Piotr, et al.
Publicado: (2022)

Cytomegalovirus infection and disease reduce 10-year cardiac allograft vasculopathy-free survival in heart transplant recipients
por: Johansson, Inger, et al.
Publicado: (2015)

Clinical implementation of coronary computed tomography angiography for routine detection of cardiac allograft vasculopathy in heart transplant patients
por: Nous, Fay M. A., et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_bgm0uq4hlbpll5j4ea51sq70hv